Positive Affective Recovery in Daily Life as a Momentary Mechanism Across Subclinical and Clinical Stages of Mental Disorder: Experience Sampling Study.
depression
ecological momentary assessment
experience sampling methodology
psychosis
resilience
stress reactivity
trajectory
transdiagnostic
Journal
JMIR mental health
ISSN: 2368-7959
Titre abrégé: JMIR Ment Health
Pays: Canada
ID NLM: 101658926
Informations de publication
Date de publication:
23 Nov 2022
23 Nov 2022
Historique:
received:
22
02
2022
accepted:
06
09
2022
revised:
06
09
2022
entrez:
23
11
2022
pubmed:
24
11
2022
medline:
24
11
2022
Statut:
epublish
Résumé
Identifying momentary risk and protective mechanisms may enhance our understanding and treatment of mental disorders. Affective stress reactivity is one mechanism that has been reported to be altered in individuals with early and later stages of mental disorder. Additionally, initial evidence suggests individuals with early and enduring psychosis may have an extended recovery period of negative affect in response to daily stressors (ie, a longer duration until affect reaches baseline levels after stress), but evidence on positive affective recovery as a putative protective mechanism remains limited. This study aimed to investigate trajectories of positive affect in response to stress across the continuum of mental disorder in a transdiagnostic sample. Using the Experience Sampling Method, minor activity-, event-, and overall stress and positive affect were assessed 10 times a day, with time points approximately 90 minutes apart on six consecutive days in a pooled data set including 367 individuals with a mental disorder, 217 individuals at risk for a severe mental disorder, and 227 controls. Multilevel analysis and linear contrasts were used to investigate trajectories of positive affect within and between groups. Baseline positive affect differed across groups, and we observed stress reactivity in positive affect within each group. We found evidence for positive affective recovery after reporting activity- or overall stress within each group. While controls recovered to baseline positive affect about 90 minutes after stress, patients and at-risk individuals required about 180 minutes to recover. However, between-group differences in the affective recovery period fell short of significance (all P>.05). The results provide first evidence that positive affective recovery may be relevant within transdiagnostic subclinical and clinical stages of mental disorder, suggesting that it may be a potential target for mobile health interventions fostering resilience in daily life.
Sections du résumé
BACKGROUND
BACKGROUND
Identifying momentary risk and protective mechanisms may enhance our understanding and treatment of mental disorders. Affective stress reactivity is one mechanism that has been reported to be altered in individuals with early and later stages of mental disorder. Additionally, initial evidence suggests individuals with early and enduring psychosis may have an extended recovery period of negative affect in response to daily stressors (ie, a longer duration until affect reaches baseline levels after stress), but evidence on positive affective recovery as a putative protective mechanism remains limited.
OBJECTIVE
OBJECTIVE
This study aimed to investigate trajectories of positive affect in response to stress across the continuum of mental disorder in a transdiagnostic sample.
METHODS
METHODS
Using the Experience Sampling Method, minor activity-, event-, and overall stress and positive affect were assessed 10 times a day, with time points approximately 90 minutes apart on six consecutive days in a pooled data set including 367 individuals with a mental disorder, 217 individuals at risk for a severe mental disorder, and 227 controls. Multilevel analysis and linear contrasts were used to investigate trajectories of positive affect within and between groups.
RESULTS
RESULTS
Baseline positive affect differed across groups, and we observed stress reactivity in positive affect within each group. We found evidence for positive affective recovery after reporting activity- or overall stress within each group. While controls recovered to baseline positive affect about 90 minutes after stress, patients and at-risk individuals required about 180 minutes to recover. However, between-group differences in the affective recovery period fell short of significance (all P>.05).
CONCLUSIONS
CONCLUSIONS
The results provide first evidence that positive affective recovery may be relevant within transdiagnostic subclinical and clinical stages of mental disorder, suggesting that it may be a potential target for mobile health interventions fostering resilience in daily life.
Identifiants
pubmed: 36416883
pii: v9i11e37394
doi: 10.2196/37394
pmc: PMC9730210
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e37394Informations de copyright
©Leonie Ader, Anita Schick, Claudia Simons, Philippe Delespaul, Inez Myin-Germeys, Thomas Vaessen, Ulrich Reininghaus. Originally published in JMIR Mental Health (https://mental.jmir.org), 23.11.2022.
Références
Psychol Assess. 2014 Jun;26(2):462-73
pubmed: 24512426
Acta Psychiatr Scand. 2017 Oct;136(4):373-388
pubmed: 28758672
Psychol Med. 2021 Oct;51(13):2217-2230
pubmed: 33682643
Psychol Med. 2015 Aug;45(11):2375-87
pubmed: 25804221
Acta Psychiatr Scand. 2020 May;141(5):465-475
pubmed: 32027017
Psychiatr Prax. 2018 Mar;45(2):59-61
pubmed: 29495051
Acta Psychiatr Scand. 2003 Feb;107(2):124-31
pubmed: 12534438
Psychol Med. 2009 Sep;39(9):1533-47
pubmed: 19215626
Psychol Med. 2009 Jul;39(7):1077-86
pubmed: 18834553
Acta Psychiatr Scand. 2013 Jul;128(1):3-20
pubmed: 23488807
Eur Psychiatry. 2017 Sep;45:81-89
pubmed: 28750277
Schizophr Bull. 2008 Nov;34(6):1066-82
pubmed: 18791076
J Affect Disord. 2016 Jan 15;190:640-648
pubmed: 26590511
Neuroimage. 2011 Oct 15;58(4):1081-9
pubmed: 21801840
Schizophr Res. 2019 Nov;213:32-39
pubmed: 30930036
Schizophr Bull. 2012 Mar;38(2):227-30
pubmed: 22355185
Ther Adv Psychopharmacol. 2011 Oct;1(5):145-51
pubmed: 23983939
Arch Gen Psychiatry. 2001 Dec;58(12):1137-44
pubmed: 11735842
Acta Psychiatr Scand. 2011 Jan;123(1):28-35
pubmed: 20712824
Curr Opin Psychiatry. 2016 Jul;29(4):258-63
pubmed: 27153125
Front Psychiatry. 2021 Jan 08;11:553578
pubmed: 33488413
Am J Psychiatry. 2000 Oct;157(10):1552-62
pubmed: 11007705
J Abnorm Psychol. 2015 Nov;124(4):878-89
pubmed: 26214708
Aust N Z J Psychiatry. 2006 Aug;40(8):616-22
pubmed: 16866756
Psychol Med. 2016 Oct;46(13):2799-813
pubmed: 27400863
J Consult Clin Psychol. 2011 Oct;79(5):618-28
pubmed: 21767001
Am J Psychiatry. 2013 Jul;170(7):695-8
pubmed: 23820827
Schizophr Bull. 2018 Feb 15;44(2):328-337
pubmed: 28338969
Psychol Med. 2012 May;42(5):1003-12
pubmed: 22067414
Psychol Med. 2013 Jul;43(7):1389-400
pubmed: 23111055
J Pers Soc Psychol. 2004 Feb;86(2):320-33
pubmed: 14769087
Acta Psychiatr Scand. 2017 Jul;136(1):63-73
pubmed: 28260264
Schizophr Bull. 2014 Jan;40(1):66-77
pubmed: 23363687
J Psychosom Res. 2006 Aug;61(2):229-36
pubmed: 16880026
Int J Methods Psychiatr Res. 2009;18(1):4-12
pubmed: 19195049
Schizophr Bull. 2008 Mar;34(2):220-5
pubmed: 18203757
Schizophr Bull. 2016 Mar;42(2):264-9
pubmed: 26707864
Eur Psychiatry. 2017 Sep;45:167-173
pubmed: 28957783
Early Interv Psychiatry. 2019 Jun;13(3):379-386
pubmed: 28984077
J Affect Disord. 2003 Sep;76(1-3):171-81
pubmed: 12943947
J Pers Soc Psychol. 2000 Jun;78(6):1135-49
pubmed: 10870914
Schizophr Bull. 2016 May;42(3):712-22
pubmed: 26834027
J Abnorm Psychol. 2008 Feb;117(1):143-53
pubmed: 18266492
J Pers. 2004 Dec;72(6):1161-90
pubmed: 15509280
Psychol Med. 2011 Nov;41(11):2305-15
pubmed: 21733219
World Psychiatry. 2018 Jun;17(2):123-132
pubmed: 29856567
Eur Child Adolesc Psychiatry. 2021 Apr;30(4):591-605
pubmed: 32405792
Depress Anxiety. 2003;18(2):76-82
pubmed: 12964174
World Psychiatry. 2018 Jun;17(2):133-142
pubmed: 29856558
Epidemiol Psychiatr Sci. 2021 May 28;30:e40
pubmed: 34044905
Ann Gen Psychiatry. 2009 Oct 08;8:22
pubmed: 19811665
JMIR Ment Health. 2022 Nov 23;9(11):e37394
pubmed: 36416883
Health Psychol. 2012 Mar;31(2):135-44
pubmed: 21988094